Intellia Therapeutics
NTLA
#5768
Rank
ยฃ0.83 B
Marketcap
ยฃ7.21
Share price
-1.33%
Change (1 day)
-32.57%
Change (1 year)

Revenue for Intellia Therapeutics (NTLA)

Revenue in 2025 (TTM): ยฃ43.75 Million

According to Intellia Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ43.18 Million. In 2024 the company made a revenue of ยฃ46.12 Million an increase over the revenue in the year 2023 that were of ยฃ28.47 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Intellia Therapeutics from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ43.75 M-5.13%
2024 ยฃ46.12 M61.98%
2023 ยฃ28.47 M-33.91%
2022 ยฃ43.08 M75.94%
2021 ยฃ24.48 M-42.45%
2020 ยฃ42.54 M29.44%
2019 ยฃ32.87 M37.1%
2018 ยฃ23.97 M24.07%
2017 ยฃ19.32 M44.7%
2016 ยฃ13.35 M227.45%
2015 ยฃ4.07 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA